Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
LPAR3 encodes a member of the G protein-coupled receptor family, as well as the EDG family of proteins. Additionally we are shipping LPAR3 Kits (15) and LPAR3 Proteins (4) and many more products for this protein.
Showing 10 out of 85 products:
Human Polyclonal LPAR3 Primary Antibody for IHC, IHC (p) - ABIN4331421
Leve, Peres-Moreira, Binato, Abdelhay, Morgado-Díaz: LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways. in PLoS ONE 2015
EDG4 (show LPAR2 Antibodies) and EDG7 map to q2.1 of pig chromosome 2 (SSC2 (show ELOVL2 Antibodies)) and q2.6-3.2 of pig chromosome6 (SSC6), respectively
EDG7 was regulated by pregnancy stage and status. EDG7 expression was highest on d 12 pregnancy, and localized to the luminal and glandular epithelium, and EDG7 mRNA levels were elevated by estrogen in the endometrium.
Expression profiles reveal LPAR3 (lysophosphatidic acid receptor 3) as a mediator for mitotic phosphorylation-driven pancreatic cell motility and invasion. Together, this work identifies YAP (show YAP1 Antibodies) as a novel regulator of pancreatic cancer cell motility, invasion and metastasis.
These data indicated that the expression of LPA receptor 3 was increased in human triple-negative breast cancers and is associated with tumor metastatic ability.
Suggest that LPA2 (show LPAR2 Antibodies) and LPA3 may function as a molecular switch and play opposing roles during megakaryopoiesis of K562 cells.
The results demonstrate LPA (show APOA Antibodies)-stimulated migration in oral carcinoma cells through LPAR3, mediated further by PKC (show PRRT2 Antibodies), which acts either in concert with or independently of EGFR (show EGFR Antibodies) transactivation
Findings indicate lysophosphatidic acid (LPA (show APOA Antibodies))-lysophosphatidic acid receptor-Galpha13 (show GNA13 Antibodies) signaling node as a therapeutic target for pancreatic cancer treatment and control.
LPA3 mRNA is clearly expressed in human PANC-1 tumor cells.
Lysophosphatidic acid (LPA) increased hepatocellular carcinoma cells cell invasion, which was LPA-receptor dependent.
in the normal human menstrual cycle, lysophosphatidic acid receptor 3 messenger RNA and protein expression change, indicating that this gene may be related to the function of the endometrium.
The results indicated that LPA(3) acts as a positive regulator of cell motility and invasion in sarcoma cells, suggesting that LPA (show APOA Antibodies) signaling pathway via LPA(3) may be involved in the progression of sarcoma cells.
High LPAR3 expression is associated with aggressiveness of breast carcinoma.
Lpar3(-/-) female mice had delayed embryo implantation.
These results suggest that LPA3 receptor-mediated amplification of spinal LPA production is required for the development of paclitaxel-induced neuropathic pain.
These results suggest that LPA signaling through LPA3 may inhibit angiogenesis and fibroblast activation in mouse lung cancer cells
The thromboxane A(2) receptor agonist 11-deoxy PGF (show PTGFR Antibodies)(2alpha) can partially alleviate embryo crowding in the Lpar3((-/-)) females and embryo crowding likely contributes to reduced litter size in the Lpar3((-/-)) females.
Lysophosphatidic acid, via LPA(1 (show LPAR1 Antibodies)) and LPA(3) receptors, may play a significant role in inducing and/or sustaining the massive infiltration of leukocytes during inflammation
Luminal epithelium localization and up-regulation by progesterone differentiate LPA3 from the other nine LP receptors and may underlie its essential role in embryo implantation.
LPA(1 (show LPAR1 Antibodies)-3) are differentially expressed in the central nervous system and their expression is upregulated in response to injury.
Lysophosphatidic acid receptors LPA3 and LPA1 (show LPAR1 Antibodies) promote CXCL12 (show CXCL12 Antibodies)-mediated smooth muscle progenitor cell recruitment.
LPA3 receptor-mediated signalling has an influence on embryo implantation, and there is a linkage between LPA signalling and prostaglandin biosynthesis.
Progesterone and estrogen cooperatively regulate LPA(3) expression, thereby contributing to the receptivity of uteri during early pregnancy.
This gene encodes a member of the G protein-coupled receptor family, as well as the EDG family of proteins. This protein functions as a cellular receptor for lysophosphatidic acid and mediates lysophosphatidic acid-evoked calcium mobilization. This receptor couples predominantly to G(q/11) alpha proteins.
endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7
, lysophosphatidic acid receptor 3
, LPA receptor 3
, LPA receptor EDG7
, calcium-mobilizing lysophosphatidic acid receptor LP-A3
, endothelial cell differentiation gene 7
, lysophosphatidic acid receptor Edg-7
, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 7
, putative G protein-coupled receptor snGPCR32